Csii investor relations

Author: emdr

August undefined, 2024

WebMar 29, 2024 · The Cardiovascular Systems stock price fell by -0.101% on the last day (Wednesday, 29th Mar 2024) from $19.86 to $19.84. During the last trading day the stock fluctuated 0.252% from a day low at $19.84 to a day high of $19.89. The price has risen in 4 of the last 10 days and is up by 0.4% over the past 2 weeks. WebNov 3, 2024. Founded. 1989. For list of CSII events, you may visit their Investor Relations website.

Cardiovascular Systems, Inc. (CSII) Q1 2024 Earnings Call Transcript

WebApr 11, 2024 · DermTech Announces Release Date for Fourth-Quarter 2024 Financial Results. Feb 09, 2024. Web2 days ago · Read the Investor Relations section for CSI, a medical device company focused on developing and commercializing innovative solutions. incite you

Q1 FY22 Earnings Supplement

WebFeb 17, 2024 · Investor Relations Cardiovascular Systems Inc CSII Executive Morningstar Rating Rating as of Feb 17, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability ... WebApr 10, 2024 · Investor Relations. Investor Relations. Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for … WebAug 2, 2024 · For the fiscal year ending Jun 2024 , the consensus EPS* forecast has remained the same over the past week at -0.67 and increased over the past month from -0.69 to -0.67 (2.90%). Of the 5 analysts ... incorporate my business canada

Cardiovascular Systems, Inc. Common Stock (CSII) Stock Price, …

News Releases AtriCure, Inc.

WebJan 9, 2024 · 2024 Worldwide revenue of $330.4 million – an increase of 20.4% year over year 2024 U.S. revenue of $277.2 million – an increase of 21.0% year over year 2024 International revenue of $53.2 million – an increase of 17.7% in 2024 MASON, Ohio --(BUSINESS WIRE)--Feb. 21, 2024-- AtriCure, Inc. WebNov 9, 2024 · Cardiovascular Systems, Inc. (NASDAQ:NASDAQ:CSII) Q1 2024 Results Earnings Conference Call November 9, 2024 9:00 AM ETCompany ParticipantsJack Nielsen - Vice President, Investor Relations... incitec dividend historyWebCorporate Governance. Cardiovascular Systems, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 2. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 5; … incitec fertilizers pty limited

"WebMar 28, 2024 · Investor Relations. Adrianne Griffin. T 214.489.7113 E [email protected]. Transfer Agent. AST. Brooklyn, New York T (800) 937-5449 www.amstock.com. Be a part of the team leading the industrial product market. Learn More. 5420 Lyndon B. Johnson Freeway " - Csii investor relations

Csii investor relations

WebOur Mission. The Coalition For Smarter Infrastructure Investments (CSII) promotes federal policies to modernize our nation's aging infrastructure by unleashing the promise of …

Did you know?

WebWe made our customer’s needs the foundation of our business. Our customers drive the solutions that we create. These solutions are tailored mixes of products and services, … WebNov 9, 2024 · Q1 FY22: U.S. Coronary 1 Is the total of Orbital Atherectomy System Revenue plus Interventional Support Device Revenue. 2 Includes coronary orbital atherectomy devices, Coronary ViperWire, ViperSlide and other 3 Includes Sapphire angioplasty balloons and Teleport microcatheters Modest Y/Y growth despite regional …

WebFeb 23, 2024 · PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and ... Investor Relations & Corporate Communications (651) 202-4919 [email protected]. Source: … WebCSII Growth Metrics. Its 2 year cash and equivalents growth rate is now at -3.76%. Its 2 year price growth rate is now at -59.11%. The 3 year cash and equivalents growth rate now …

WebFeb 12, 2024 · Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 41.393. In total, the insiders bought 582 193 and sold 291 699 CSII shares in the last 100 trades. WebJan 13, 2024 · PAUL, Minn.-- (BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative …

WebVice President, Investor Relations & Corporate Communications Jeffrey W. Chambers, M.D. Chief Medical Officer Joined CSI in 2024 Rejoined CSI in 2024 Joined CSI in 2015 Joined CSI in 2014 Sandra M. Sedo Chief Compliance Officer Andrew P. O’Brien Vice President, Information Technology Jeffrey S. Points Chief Financial Officer

WebFeb 8, 2024 · CSI’s fiscal 2024 second quarter revenues were $61.5 million, representing an increase of $2.3 million, or 3.9% compared to the second quarter last year. Gross profit … incorporate more vegetablesWebFeb 13, 2024 · Investor Relations. Investor Relations. Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for … incorporate my business californiaWebCSII Investor Presentation - s22.q4cdn.com incorporate my business in marylandWebs22.q4cdn.com incitec dynoWeb简; en; 登录 / 注册 incorporate my business irsWebAug 3, 2024 · This document is intended to be read by investors in advance of regularly scheduled quarterly conference calls and was designed to provide a review of Glaukos Corporation’s recent financial and operational performance and general business outlook. Please see “Forward-Looking Statements” and “Statement Regarding Use of Non-GAAP … incitec fertiliser product listWebWant to learn more about how to be a change maker and industry shaper like our 1,000-plus clients? Visit csgi.com to learn more. Jordy Spitale. Public Relations. +1 (504) 615-8820. [email protected]. John … incorporate my business online